Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

US Patent 12215387 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of mavoglurant in the reduction of alcohol use or in preventing relapse into2025
Use of mavoglurant in the reduction of alcohol use or in preventing relapse into2025
Methods of treating dry eye disease using TNF alpha antagonists2024
Use of mavoglurant in the reduction of cocaine use or in preventing relapse into2024
Use of mavoglurant in the reduction of cocaine use or in preventing relapse into2024
Methods of treating ophthalmic disorders2023
TREM2 stabilizing antibodies2022
Use of a H3R inverse agonist for the treatment of shift work disorder2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022